News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aperio Technologies, Inc. Further Strengthens Its Board of Directors with the Addition of Thomas Bologna



5/20/2011 10:39:51 AM

Aperio, the global leader in providing digital pathology solutions that improve patient care, today announced that it has appointed Thomas Bologna, President & Chief Executive Officer of Orchid Cellmark, Inc. (NASDAQ: ORCH), a leading service provider of DNA identity testing, to its Board of Directors. Last week, Aperio announced that healthcare veteran David Schlotterbeck had also joined its Board.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES